Reduced healing time

Developed in 1998, SLA^® set the gold standard by halving the average healing time from 12 weeks to 6-8 weeks. SLActive cuts the healing time once more in half by reliably offering sufficient secondary stability for early loading already at 3-4 weeks after implant placement.

Higher treatment predictability and reduced risks

Compared to SLA, SLActive provides 60% more bone-to-implant contact two weeks after insertion, as shown in animal tests. This substantially higher BIC-value results in improved treatment predictability for all protocols and helps to minimize the potential for early implant failures.

New treatment options

Although implants with SLActive surface are suitable for all indications, the high treatment-security they provide render them especially beneficial to advanced and complex treatment protocols in challenging indications.